Target intelligence / Profile preview

Ebolavirus glycoprotein base region (GP1 base region) (GP base region or GP1 base)

Target
GP base region or GP1 base
Molecular classification
Viral envelope protein, Class I viral fusion protein, Receptor-binding protein
01

Overview

The "Ebolavirus GP base region" refers to a specific subdomain within the Ebolavirus glycoprotein (GP), which is a critical envelope protein involved in virus entry into host cells. The GP is cleaved into two subunits: GP1 (responsible for cell attachment) and GP2 (mediates membrane fusion). The base region is part of GP1 and lies adjacent to GP2, forming structural and functional interfaces crucial for viral infection. The Ebolavirus glycoprotein base region is a structurally distinct portion of the surface glycoprotein GP, specifically within the GP1 subunit. It forms a semi-circular, hydrophobic interface that interacts intimately with the internal fusion loop and heptad repeat of GP2, stabilizing the prefusion conformation of the viral envelope. It contains critical cysteine residues that form disulfide bonds with GP2 and is a key structural clamp preventing premature fusion activation. The base region is a major epitope for broadly neutralizing antibodies, making it an attractive therapeutic target. Because GP is the only surface protein of Ebolavirus, its base region is central to viral attachment to host cells, membrane fusion, and entry. Targeting the base region with antibodies or inhibitors can block viral infection, and its unique features differentiate it from other viral fusion proteins, such as those found in HIV and influenza. The base region includes residues 33–69, 95–104, 158–167, and 176–189 (GP1). It is partly occluded by glycan and mucin-like domains before proteolytic cleavage in the host endosome, which is necessary for exposure of the receptor-binding site. The region's flexible and hydrophobic nature is essential for the tightly regulated fusion process and is recognized by survivorship-derived neutralizing antibodies, such as KZ52 and mAb114. Experimental disruption of key lysine residues (K95, K114, K115, K140) in the base region impairs host cell binding, demonstrating its functional significance.

Other names
GP1 base regionEbola GP baseEbolavirus GP1 baseEbola glycoprotein base
02

Mechanism of action

Direct inhibition (neutralization) of the GP base region blocks virus-cell interaction and membrane fusion. Steric (physical) occlusion of receptor-binding sites by targeted antibodies or molecules.

03

Biological functions

Viral attachmentStabilization of the fusion-active conformationAntibody recognition (neutralizing epitope)Structural interaction with fusion machinery
04

Disease associations

Infection (Ebola virus disease)
05

Safety considerations

Viral cytotoxicity and immune evasion (due to GP's occlusive properties)Mutational variability of GP may reduce antibody efficacyRisk of immune enhancement if non-neutralizing antibodies are generated
06

Interacting drugs

Monoclonal antibodies (e.g., KZ52, mAb114)

1 more in the full profile.

07

Biomarkers

Detection of anti-GP antibodies in bloodPresence of soluble GP fragments may aid disease diagnosis

Beyond the preview

Go deeper on Ebolavirus glycoprotein base region (GP1 base region) (GP base region or GP1 base).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ebolavirus glycoprotein base region (GP1 base region) (GP base region or GP1 base).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call